Topic: Benlysta
A new vaccine-like therapy that summons a host of antibodies to fight lupus has shown promise in early European trials, researchers said at a US conference on Tuesday.There are very few options for treating the potentially fatal disease in which the body's ...
LONDON (Reuters) - Britain's highest court upheld a patent on Wednesday on a gene sequence held by Human Genome Sciences related to its new lupus drug Benlysta, in a defeat for rival drugmaker Eli Lilly.The UK Supreme Court ruling chimes with similar ...
LONDON (Reuters) - Benlysta, the first new treatment for lupus in half a century, was approved for use in Europe, the drug's discoverer Human Genome Sciences and partner GlaxoSmithKline said on Thursday.The drug, which combats lupus -- a disease that causes the ...
LONDON (Reuters) - The first new treatment for lupus in a half-century was recommended for approval in Europe on Friday, offering a new option for patients and underpinning multibillion-dollar" class="inform">dollar sales expectations for its makers.The companies said the European Medicines Agency had ...
